Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia

Abstract

Pre-eclampsia is a principal cause of maternal morbidity and mortality, affecting 5–10% of first pregnancies worldwide. Manifestations include increased blood pressure, proteinuria, coagulopathy and peripheral and cerebral oedema. Although the aetiology and pathogenesis remain to be elucidated, the placenta is undoubtedly involved, as termination of pregnancy eradicates the disease. Here we have cloned a complementary DNA from human placental messenger RNA encoding a precursor protein of 121 amino acids which gives rise to a mature peptide identical to the neuropeptide neurokinin B (NKB)1 of other mammalian species. In female rats, concentrations of NKB several-fold above that of an animal 20 days into pregnancy caused substantial pressor activity. In human pregnancy, the expression of NKB was confined to the outer syncytiotrophoblast of the placenta, significant concentrations of NKB could be detected in plasma as early as week 9, and plasma concentrations of NKB were grossly elevated in pregnancy-induced hypertension and pre-eclampsia. We conclude that elevated levels of NKB in early pregnancy may be an indicator of hypertension and pre-eclampsia, and that treatment with certain neurokinin receptor antagonists may be useful in alleviating the symptoms.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Localization of neurokinin B mRNA expression in vertical sections of the placenta.
Figure 2: Neurokinin B levels in the plasma of 30 normotensive women (filled circles) were determined in samples taken throughout pregnancy and at term in 16 different women (open circles).
Figure 3: Changes in heart rate and blood pressure during infusion of saline (open circles, n = 3) or incremental doses of NKB (filled circles, n = 6) in conscious unrestrained female rats.

Similar content being viewed by others

References

  1. Kangawa, K., Minamino, N., Fukuda, A. & Matsuo, H. Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 114, 533– 540 (1983).

    Article  CAS  Google Scholar 

  2. von Euler, U. S. & Gaddum, J. H. An unidentified depressor substance in certain tissue extracts. J. Physiol. 72, 74–87 (1931).

    Article  Google Scholar 

  3. Kimura, S., Okada, K., Sugita, Y., Kanazawa, I. & Munekata, E. Novel peptides neuropeptides, neurokinin α and β, isolated from porcine spinal cord. Proc. Japan Acad. B 59, 101–104 (1983).

    Article  CAS  Google Scholar 

  4. Longmore, J., Hill, R. G. & Hargreaves, R. J. Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs. Canadian J. Physio. & Pharmacol. 75, 612–621 ( 1997).

    Article  CAS  Google Scholar 

  5. Mastrangelo, D. et al. The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. Eur. J. Pharmacol. 134, 321–326 (1987).

    Article  CAS  Google Scholar 

  6. D'Orleans-Juste, P., Claing, A., Telemaque, S., Warner, T. D. & Regoli, D. Neurokinins produce selective venoconstriction via NK-3 receptors in the rat mesenteric vascular bed. Eur. J. Pharmacol. 204, 329–334 (1991).

    Article  CAS  Google Scholar 

  7. Thompson, G. W., Hoover, D. B., Ardell, J. L. & Armour, J. A. Canine intrinsic cardiac neurons involved in cardiac regulation possess NK1, NK2 and NK3 receptors. Am. J. Physiol.-Regul. Integrative Comp. Physiol. 44, 1683–1689 ( 1998).

    Article  Google Scholar 

  8. Moussaoui, S. M. et al. Distribution of neurokinin B in rat spinal cord and peripheral tissues: comparison with neurokinin A and substance P and effects of neonatal capsaican treatment. Neuroscience 48, 969 –978 (1992).

    Article  CAS  Google Scholar 

  9. Jansen, I., Alafaci, C., McCulloch, J., Uddman, R. & Edvinsson, L. Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: vasomotor responses in vitro and in situ. J. Cereb. Blood Flow Metab. 11, 567–575 ( 1991).

    Article  CAS  Google Scholar 

  10. Baumann, H. & Huch, R. Maternal hemodynamics in pregnancy. Am. J. Obstet. Gynecol. 165, 237– 238 (1991).

    Article  CAS  Google Scholar 

  11. Lim, K. H. et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am. J. Pathol. 151, 1809 –1818 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Lyall, F. & Greer, I. A. The vascular endothelium in normal pregnancy and pre-eclampsia. Rev. Reprod. 1, 107–116 (1996).

    Article  CAS  Google Scholar 

  13. Hayman, R., Brockelsby, J., Kenny, L. & Baker, P. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J. Soc. Gynecol. Investig. 6, 3–10 (1999).

    Article  CAS  Google Scholar 

  14. Campbell, A. et al. Plasma corticotrophin-releasing hormone concentrations during pregnancy and parturition. J. Clin. Endocrinol. Metab. 64, 1054–1059 (1987).

    Article  CAS  Google Scholar 

  15. Page, N. M., Manyonda, I., Butlin, D. J., Bicknell, A. B. & Lowry, P. J. Identification of novel differentially expressed secretory proteins from the human placenta. J. Endocr. 156 (Suppl.), P257 (1998).

    Google Scholar 

  16. Boguski, M. S., Lowe, T. M. & Tolstoshev, C. M. dbEST—database for “expressed sequence tags”. Nature Genet. 4, 332– 333 (1993).

    Article  CAS  Google Scholar 

  17. Adams, M. D. et al. Initial assessment of human gene diversity and expression patterns based upon 83-million nucleotides of cDNA sequence. Nature 377, Genome Directory 3S (1995).

  18. Couture, R., Laneuville, O., Guimond, C., Drapeau, G. & Regoli, D. Characterization of the peripheral actions of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Naunyn Schmied. Arch. Pharmacol. 340, 547–557 (1989).

    Article  CAS  Google Scholar 

  19. Cellier, E., Barbot, L., Regoli, D. & Couture, R. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat. Br. J. Pharmacol. 122, 643–654 ( 1997).

    Article  CAS  Google Scholar 

  20. Roccon, A., Marchionni, D. & Nisato, D. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig. Brit. J. Pharmacol. 118, 1095–1102 (1996).

    Article  CAS  Google Scholar 

  21. Conrad, K. P., Kerchner, L. J. & Mosher, M. D. Plasma and 24h NOx and cGMP during normal pregnancy and preeclampsia in women on a reduced NOx diet. Am. J. Physiol. 46, F48–F57 ( 1999).

    Google Scholar 

  22. Gecse, A., Kis, B., Mezei, Z. & Telegdy, G. The effect of bradykinin and substance P on the arachidonate cascade of platelets. Immunopharmacology 33, 167–170 (1996).

    Article  CAS  Google Scholar 

  23. Perianin, A., Snyderman, R. & Malfroy, B. Substance P primes human neutrophil activation: a mechanism for neurological regulation of inflammation. Biochem. Biophys. Res. Commun. 161, 520–524 (1989)

    Article  CAS  Google Scholar 

  24. Perretti, M., Ahluwalia, A., Flower, R J. & Manzini, S. Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors. Immunology 80, 73–77 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Kobari, M. et al. Intravascular substance P dilates cerebral parenchymal vessels through a specific tachykinin NK1 receptor in cats. Eur. J. Pharmacol. 317, 269–274 ( 1996).

    Article  CAS  Google Scholar 

  26. Shimizu, T. et al. Occurrence and distribution of substance P receptors in the cerebral blood vessels of the rat. Brain Res. 830, 372–378 (1999).

    Article  CAS  Google Scholar 

  27. Stables, J. M. et al. GR138676, a novel peptidic tachykinin antagonist which is potent at NK3 receptors. Neuropeptides 27, 333–341 (1994).

    Article  CAS  Google Scholar 

  28. Baigent, S. M. & Lowry, P. J. Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide. J. Mol. Endocrinol. 24, 53–63 (2000).

    Article  CAS  Google Scholar 

  29. Clement-Jones, V., Lowry, P. J., Rees, L. H. & Besser, G. M. Met-enkephalin circulates in human plasma. Nature 283 , 295–297 (1980).

    Article  ADS  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Medical Research Council.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. J. Lowry.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Page, N., Woods, R., Gardiner, S. et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 405, 797–800 (2000). https://doi.org/10.1038/35015579

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/35015579

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing